Is Time Nearly Up For Pear? The PDT Company Could Be Bargain For Acquirer

Despite earlier efforts to restructure, the company is still struggling to meet its revenue targets, and issued a statement suggesting that further measures, including liquidation, may be necessary.

The cost-cutting plan Pear Therapeutics announced in July has not done enough to change the company’s financial outlook, suggesting the company’s strategy to sell digital therapeutics to state health agencies is not nearly as effective as the company’s investors had hoped.

The restructuring plan that Pear announced last summer included two rounds of layoffs, cutting about 20% of the company’s staff. At the time, the company hoped these job cuts could...

More from Financing

More from Business